Hepatitis B Outcomes After Switching to Long-Acting Cabotegravir/Rilpivirine in People With HIV: Reactivation, Incident Infection, and Liver Safety Across Diverse Serological Profiles

Alberto Foncillas, Juan Ambrosioni, Abiu Sempere, Leire Berrocal, Julia Calvo, Iván Chivite, Lorena de la Mora, Alexy Inciarte, Berta Torres, María Martínez-Rebollar, José Luis Blanco, José M Miró, Elisa de Lazzari, Esteban Martínez, Josep Mallolas, Ana González-Cordón, Montserrat Laguno

Open source

DOI: 10.1093/cid/ciag023
Published: 2026-01-14
Container: Clinical Infectious Diseases
Publisher: Oxford University Press (OUP)
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1093/cid/ciag023,
  title = {Hepatitis B Outcomes After Switching to Long-Acting Cabotegravir/Rilpivirine in People With HIV: Reactivation, Incident Infection, and Liver Safety Across Diverse Serological Profiles},
  author = {Alberto Foncillas and Juan Ambrosioni and Abiu Sempere and Leire Berrocal and Julia Calvo and Iván Chivite and Lorena de la Mora and Alexy Inciarte and Berta Torres and María Martínez-Rebollar and José Luis Blanco and José M Miró and Elisa de Lazzari and Esteban Martínez and Josep Mallolas and Ana González-Cordón and Montserrat Laguno},
  year = {2026},
  journal = {Clinical Infectious Diseases},
  doi = {10.1093/cid/ciag023},
  url = {https://doi.org/10.1093/cid/ciag023}
}

RIS

TY  - JOUR
TI  - Hepatitis B Outcomes After Switching to Long-Acting Cabotegravir/Rilpivirine in People With HIV: Reactivation, Incident Infection, and Liver Safety Across Diverse Serological Profiles
AU  - Alberto Foncillas
AU  - Juan Ambrosioni
AU  - Abiu Sempere
AU  - Leire Berrocal
AU  - Julia Calvo
AU  - Iván Chivite
AU  - Lorena de la Mora
AU  - Alexy Inciarte
AU  - Berta Torres
AU  - María Martínez-Rebollar
AU  - José Luis Blanco
AU  - José M Miró
AU  - Elisa de Lazzari
AU  - Esteban Martínez
AU  - Josep Mallolas
AU  - Ana González-Cordón
AU  - Montserrat Laguno
PY  - 2026
JO  - Clinical Infectious Diseases
DO  - 10.1093/cid/ciag023
UR  - https://doi.org/10.1093/cid/ciag023
ER  -

APA

Foncillas, A., Ambrosioni, J., Sempere, A., Berrocal, L., Calvo, J., Chivite, I., Mora, L. D. L., Inciarte, A., Torres, B., Martínez-Rebollar, M., Blanco, J. L., Miró, J. M., Lazzari, E. D., Martínez, E., Mallolas, J., González-Cordón, A., & Laguno, M. (2026). Hepatitis B Outcomes After Switching to Long-Acting Cabotegravir/Rilpivirine in People With HIV: Reactivation, Incident Infection, and Liver Safety Across Diverse Serological Profiles. Clinical Infectious Diseases. https://doi.org/10.1093/cid/ciag023

Source records

crossref · retrieved 2026-11-05T21:52:43.408Z